Amyloid precursor protein (APP) and cholesterol metabolism are genetically linked to Alzheimer's disease, the latter through apolipoprotein E, a lipid and cholesterol transport protein. We have examined the hypothesis that the processing of APP is disrupted by elevated cholesterol, which is known to modulate the activity of several transmembrane proteins. In the current study, cholesterol, solubilized by methyl--cyclodextrin or ethanol, was added to the culture media of APP 751 stably transfected HEK 293 cells. Radiolabeled APP and APP (the soluble N-terminal derivative following -secretase cleavage) were precipitated from lysates and conditioned media of stably transfected HEK 293 cells; the relative levels were determined by quantitative densitometry following separation by SDS-polyacrylamide gel electrophoresis. The data show that cholesterol, solubilized by methyl--cyclodextrin, greatly reduced the levels of APP. Low doses of ethanol-solubilized cholesterol similarly caused a dramatic reduction of APP. By contrast, levels of APP holoprotein remained the same or increased. The large decrease seen in APP production was not due to nonspecific inhibition of secretion because several secreted proteins increased in level. Cholesterol, which impedes membrane fluidity, may lower APP production by impeding the interaction of the substrate with its protease(s). If APP were to function trophically, as suggested by other studies, the current conclusion suggests that changes in cellular cholesterol levels in Alzheimer's disease could contribute to neuronal degeneration by decreasing the production of APP.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. W. Halford and D. W. Russell Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan PNAS, March 3, 2009; 106(9): 3502 - 3506. [Abstract] [Full Text] [PDF]

				P. Osenkowski, W. Ye, R. Wang, M. S. Wolfe, and D. J. Selkoe Direct and Potent Regulation of {gamma}-Secretase by Its Lipid Microenvironment J. Biol. Chem., August 15, 2008; 283(33): 22529 - 22540. [Abstract] [Full Text] [PDF]

				B. L. Burgess, P. F. Parkinson, M. M. Racke, V. Hirsch-Reinshagen, J. Fan, C. Wong, S. Stukas, L. Theroux, J. Y. Chan, J. Donkin, et al. ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo J. Lipid Res., June 1, 2008; 49(6): 1254 - 1267. [Abstract] [Full Text] [PDF]

				H.-S. Hoe, M. J. Cooper, M. P. Burns, P. A. Lewis, M. van der Brug, G. Chakraborty, C. M. Cartagena, D. T. S. Pak, M. R. Cookson, and G. W. Rebeck The Metalloprotease Inhibitor TIMP-3 Regulates Amyloid Precursor Protein and Apolipoprotein E Receptor Proteolysis J. Neurosci., October 3, 2007; 27(40): 10895 - 10905. [Abstract] [Full Text] [PDF]

				G. H. Tansley, B. L. Burgess, M. T. Bryan, Y. Su, V. Hirsch-Reinshagen, J. Pearce, J. Y. Chan, A. Wilkinson, J. Evans, K. E. Naus, et al. The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of {beta}-amyloid precursor protein J. Lipid Res., May 1, 2007; 48(5): 1022 - 1034. [Abstract] [Full Text] [PDF]

				W. S. Kim, A. S. Rahmanto, A. Kamili, K.-A. Rye, G. J. Guillemin, I. C. Gelissen, W. Jessup, A. F. Hill, and B. Garner Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-beta Peptide Generation J. Biol. Chem., February 2, 2007; 282(5): 2851 - 2861. [Abstract] [Full Text] [PDF]

				S. Ye, Y. Huang, K. Mullendorff, L. Dong, G. Giedt, E. C. Meng, F. E. Cohen, I. D. Kuntz, K. H. Weisgraber, and R. W. Mahley Apolipoprotein (apo) E4 enhances amyloid {beta} peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target PNAS, December 20, 2005; 102(51): 18700 - 18705. [Abstract] [Full Text] [PDF]

				I Masse, R Bordet, D Deplanque, A Al Khedr, F Richard, C Libersa, and F Pasquier Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1624 - 1629. [Abstract] [Full Text] [PDF]

				L. Kalvodova, N. Kahya, P. Schwille, R. Ehehalt, P. Verkade, D. Drechsel, and K. Simons Lipids as Modulators of Proteolytic Activity of BACE: INVOLVEMENT OF CHOLESTEROL, GLYCOSPHINGOLIPIDS, AND ANIONIC PHOSPHOLIPIDS IN VITRO J. Biol. Chem., November 4, 2005; 280(44): 36815 - 36823. [Abstract] [Full Text] [PDF]

				A. Cordle, J. Koenigsknecht-Talboo, B. Wilkinson, A. Limpert, and G. Landreth Mechanisms of Statin-mediated Inhibition of Small G-protein Function J. Biol. Chem., October 7, 2005; 280(40): 34202 - 34209. [Abstract] [Full Text] [PDF]

				S. L. Cole, A. Grudzien, I. O. Manhart, B. L. Kelly, H. Oakley, and R. Vassar Statins Cause Intracellular Accumulation of Amyloid Precursor Protein, {beta}-Secretase-cleaved Fragments, and Amyloid {beta}-Peptide via an Isoprenoid-dependent Mechanism J. Biol. Chem., May 13, 2005; 280(19): 18755 - 18770. [Abstract] [Full Text] [PDF]

				A. B. Reiss Cholesterol and apolipoprotein E in Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias, March 1, 2005; 20(2): 91 - 96. [Abstract] [PDF]

				A. Cordle and G. Landreth 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate {beta}-Amyloid-Induced Microglial Inflammatory Responses J. Neurosci., January 12, 2005; 25(2): 299 - 307. [Abstract] [Full Text] [PDF]

				Y. Liu, L. Yang, K. Conde-Knape, D. Beher, M. S. Shearman, and N. S. Shachter Fatty acids increase presenilin-1 levels and {gamma}-secretase activity in PSwt-1 cells J. Lipid Res., December 1, 2004; 45(12): 2368 - 2376. [Abstract] [Full Text] [PDF]

				X. Bi, M. Baudry, J. Liu, Y. Yao, L. Fu, F. Brucher, and G. Lynch Inhibition of Geranylgeranylation Mediates the Effects of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Inhibitors on Microglia J. Biol. Chem., November 12, 2004; 279(46): 48238 - 48245. [Abstract] [Full Text] [PDF]

				K. M. Mann, F. E. Thorngate, Y. Katoh-Fukui, H. Hamanaka, D. L. Williams, S. Fujita, and B. T. Lamb Independent effects of APOE on cholesterol metabolism and brain A{beta} levels in an Alzheimer disease mouse model Hum. Mol. Genet., September 1, 2004; 13(17): 1959 - 1968. [Abstract] [Full Text] [PDF]

				I. Bjorkhem and S. Meaney Brain Cholesterol: Long Secret Life Behind a Barrier Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 806 - 815. [Abstract] [Full Text]

				N. Sawamura, M. Ko, W. Yu, K. Zou, K. Hanada, T. Suzuki, J.-S. Gong, K. Yanagisawa, and M. Michikawa Modulation of Amyloid Precursor Protein Cleavage by Cellular Sphingolipids J. Biol. Chem., March 19, 2004; 279(12): 11984 - 11991. [Abstract] [Full Text] [PDF]

				R. A. Nixon Niemann-Pick Type C Disease and Alzheimer's Disease: The APP-Endosome Connection Fattens Up Am. J. Pathol., March 1, 2004; 164(3): 757 - 761. [Abstract] [Full Text] [PDF]

				L. Li, D. Cao, D. W. Garber, H. Kim, and K.-i. Fukuchi Association of Aortic Atherosclerosis with Cerebral {beta}-Amyloidosis and Learning Deficits in a Mouse Model of Alzheimer's Disease Am. J. Pathol., December 1, 2003; 163(6): 2155 - 2164. [Abstract] [Full Text]

				N. B. Chauhan Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease J. Lipid Res., November 1, 2003; 44(11): 2019 - 2029. [Abstract] [Full Text]

				A. E. Roher, C. Esh, T. A. Kokjohn, W. Kalback, D. C. Luehrs, J. D. Seward, L. I. Sue, and T. G. Beach Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer's Disease Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2055 - 2062. [Abstract] [Full Text] [PDF]

				Q.-C. Cheng, O. Tikhomirov, W. Zhou, and G. Carpenter Ectodomain Cleavage of ErbB-4: CHARACTERIZATION OF THE CLEAVAGE SITE AND m80 FRAGMENT J. Biol. Chem., October 3, 2003; 278(40): 38421 - 38427. [Abstract] [Full Text] [PDF]

				R. L. Raffai and K. H. Weisgraber Cholesterol: from heart attacks to Alzheimer's disease J. Lipid Res., August 1, 2003; 44(8): 1423 - 1430. [Abstract] [Full Text] [PDF]

				M.A. Pappolla, T.K. Bryant-Thomas, D. Herbert, J. Pacheco, M. Fabra Garcia, M. Manjon, X. Girones, T.L. Henry, E. Matsubara, D. Zambon, et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology Neurology, July 22, 2003; 61(2): 199 - 205. [Abstract] [Full Text] [PDF]

				M. Burns, K. Gaynor, V. Olm, M. Mercken, J. LaFrancois, L. Wang, P. M. Mathews, W. Noble, Y. Matsuoka, and K. Duff Presenilin Redistribution Associated with Aberrant Cholesterol Transport Enhances {beta}-Amyloid Production In Vivo J. Neurosci., July 2, 2003; 23(13): 5645 - 5649. [Abstract] [Full Text] [PDF]

				E. G. Lund, C. Xie, T. Kotti, S. D. Turley, J. M. Dietschy, and D. W. Russell Knockout of the Cholesterol 24-Hydroxylase Gene in Mice Reveals a Brain-specific Mechanism of Cholesterol Turnover J. Biol. Chem., June 13, 2003; 278(25): 22980 - 22988. [Abstract] [Full Text] [PDF]

				U. Igbavboa, J. M. Pidcock, L. N. A. Johnson, T. M. Malo, A. E. Studniski, S. Yu, G. Y. Sun, and W. G. Wood Cholesterol Distribution in the Golgi Complex of DITNC1 Astrocytes Is Differentially Altered by Fresh and Aged Amyloid beta -Peptide-(1-42) J. Biol. Chem., May 2, 2003; 278(19): 17150 - 17157. [Abstract] [Full Text] [PDF]

				R. P. Koldamova, I. M. Lefterov, M. D. Ikonomovic, J. Skoko, P. I. Lefterov, B. A. Isanski, S. T. DeKosky, and J. S. Lazo 22R-Hydroxycholesterol and 9-cis-Retinoic Acid Induce ATP-binding Cassette Transporter A1 Expression and Cholesterol Efflux in Brain Cells and Decrease Amyloid beta Secretion J. Biol. Chem., April 4, 2003; 278(15): 13244 - 13256. [Abstract] [Full Text] [PDF]

				A. Papassotiropoulos, J. R. Streffer, M. Tsolaki, S. Schmid, D. Thal, F. Nicosia, V. Iakovidou, A. Maddalena, D. Lutjohann, E. Ghebremedhin, et al. Increased Brain {beta}-Amyloid Load, Phosphorylated Tau, and Risk of Alzheimer Disease Associated With an Intronic CYP46 Polymorphism Arch Neurol, January 1, 2003; 60(1): 29 - 35. [Abstract] [Full Text] [PDF]

				N. ARISPE and M. DOH Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease A{beta}P (1-40) and (1-42) peptides FASEB J, October 1, 2002; 16(12): 1526 - 1536. [Abstract] [Full Text] [PDF]

				D. Lutjohann, A. Brzezinka, E. Barth, D. Abramowski, M. Staufenbiel, K. von Bergmann, K. Beyreuther, G. Multhaup, and T. A. Bayer Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain J. Lipid Res., July 1, 2002; 43(7): 1078 - 1085. [Abstract] [Full Text] [PDF]

				M. Jaworska-Wilczynska, G. M. Wilczynski, W. K. Engel, D. K. Strickland, K. H. Weisgraber, and V. Askanas Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle Neurology, February 12, 2002; 58(3): 438 - 445. [Abstract] [Full Text] [PDF]

				S. Locatelli, D. Lutjohann, H. H.-J. Schmidt, C. Otto, U. Beisiegel, and K. von Bergmann Reduction of Plasma 24S-Hydroxycholesterol (Cerebrosterol) Levels Using High-Dosage Simvastatin in Patients With Hypercholesterolemia: Evidence That Simvastatin Affects Cholesterol Metabolism in the Human Brain Arch Neurol, February 1, 2002; 59(2): 213 - 216. [Abstract] [Full Text] [PDF]

				W. Reynish, S. Andrieu, F. Nourhashemi, and B. Vellas Nutritional Factors and Alzheimer's Disease J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2001; 56(11): M675 - 680. [Abstract] [Full Text] [PDF]

				G. P. Lim, T. Chu, F. Yang, W. Beech, S. A. Frautschy, and G. M. Cole The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse J. Neurosci., November 1, 2001; 21(21): 8370 - 8377. [Abstract] [Full Text] [PDF]

				L. J. Launer, L. R. White, H. Petrovitch, G. W. Ross, and J. D. Curb Cholesterol and neuropathologic markers of AD: A population-based autopsy study Neurology, October 23, 2001; 57(8): 1447 - 1452. [Abstract] [Full Text] [PDF]

				S. V. Chochina, N. A. Avdulov, U. Igbavboa, J. P. Cleary, E. O. O'Hare, and W. G. Wood Amyloid {beta}-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region J. Lipid Res., August 1, 2001; 42(8): 1292 - 1297. [Abstract] [Full Text] [PDF]

				M. Kivipelto, E.-L. Helkala, T. Hanninen, M. P. Laakso, M. Hallikainen, K. Alhainen, H. Soininen, J. Tuomilehto, and A. Nissinen Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study Neurology, June 26, 2001; 56(12): 1683 - 1689. [Abstract] [Full Text] [PDF]

				B. Wolozin A fluid connection: Cholesterol and Abeta PNAS, May 8, 2001; 98(10): 5371 - 5373. [Full Text] [PDF]

				E. Kojro, G. Gimpl, S. Lammich, W. März, and F. Fahrenholz Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10 PNAS, April 12, 2001; (2001) 81612998. [Abstract] [Full Text]

				N. Demeester, G. Castro, C. Desrumaux, C. De Geitere, J. C. Fruchart, P. Santens, E. Mulleners, S. Engelborghs, P. P. De Deyn, J. Vandekerckhove, et al. Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease J. Lipid Res., June 1, 2000; 41(6): 963 - 974. [Abstract] [Full Text]

				H. Hamanaka, Y. Katoh-Fukui, K. Suzuki, M. Kobayashi, R. Suzuki, Y. Motegi, Y. Nakahara, A. Takeshita, M. Kawai, K. Ishiguro, et al. Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice Hum. Mol. Genet., February 12, 2000; 9(3): 353 - 361. [Abstract] [Full Text] [PDF]

				G. K. Gouras, H. Xu, R. S. Gross, J. P. Greenfield, B. Hai, R. Wang, and P. Greengard Testosterone reduces neuronal secretion of Alzheimer's beta -amyloid peptides PNAS, February 1, 2000; 97(3): 1202 - 1205. [Abstract] [Full Text] [PDF]

				S. Maekawa, C. Sato, K. Kitajima, N. Funatsu, H. Kumanogoh, and Y. Sokawa Cholesterol-dependent Localization of NAP-22 on a Neuronal Membrane Microdomain (Raft) J. Biol. Chem., July 23, 1999; 274(30): 21369 - 21374. [Abstract] [Full Text] [PDF]

				D. S. Howland, S. P. Trusko, M. J. Savage, A. G. Reaume, D. M. Lang, J. D. Hirsch, N. Maeda, R. Siman, B. D. Greenberg, R. W. Scott, et al. Modulation of Secreted beta -Amyloid Precursor Protein and Amyloid beta -Peptide in Brain by Cholesterol J. Biol. Chem., June 26, 1998; 273(26): 16576 - 16582. [Abstract] [Full Text] [PDF]

				T. Ikezu, B. D. Trapp, K. S. Song, A. Schlegel, M. P. Lisanti, and T. Okamoto Caveolae, Plasma Membrane Microdomains for alpha -Secretase-mediated Processing of the Amyloid Precursor Protein J. Biol. Chem., April 24, 1998; 273(17): 10485 - 10495. [Abstract] [Full Text] [PDF]

				T. Yamazaki, T.-Y. Chang, C. Haass, and Y. Ihara Accumulation and Aggregation of Amyloid beta -Protein in Late Endosomes of Niemann-Pick Type C Cells J. Biol. Chem., February 2, 2001; 276(6): 4454 - 4460. [Abstract] [Full Text] [PDF]

				A. Kakio, S.-i. Nishimoto, K. Yanagisawa, Y. Kozutsumi, and K. Matsuzaki Cholesterol-dependent Formation of GM1 Ganglioside-bound Amyloid beta -Protein, an Endogenous Seed for Alzheimer Amyloid J. Biol. Chem., June 29, 2001; 276(27): 24985 - 24990. [Abstract] [Full Text] [PDF]

				E. Kojro, G. Gimpl, S. Lammich, W. Marz, and F. Fahrenholz From the Cover: Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10 PNAS, May 8, 2001; 98(10): 5815 - 5820. [Abstract] [Full Text] [PDF]